Sonnet BioTherapeutics Holdings

Youtube Subscribe

Open: 0.87 Close: 0.82 Change: -0.05

How to get information about Sonnet BioTherapeutics Holdings Company Inc without reading the whole internet.

The game is changing. There is a new strategy to evaluate Sonnet BioTherapeutics Holdings fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Sonnet BioTherapeutics Holdings are: Sonnet, BioTherapeutics, Holdings, Inc, SONN, …

Concept Map

Semantic Network

Stock Summary

Sonnet BioTherapeutics Holdings, Inc. develops platform for biologic medicines of single or bispecific action. Lead product candidate is SON-1010, a fully human version of interleukin 12 for the treatment.

Today's Summary

Sonnet BioTherapeutics Holdings Inc. (SONN) up 11.83% Friday, June 16, 2023. Premarket Mover: Sonnet Biotherapeutics holdings, inc. (sonn) Up 11.33% Friday. Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) has outstanding potential – stocks register. Sonnet Biotherapeutics holdings inc. (nasdaq: sonn)

Today's News

Sonnet BioTherapeutics Holdings Inc. (SONN) up 11.83% Friday, June 16, 2023. Premarket Mover: Sonnet Biotherapeutics holdings, inc. (sonn) Up 11.33% Friday. Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) has outstanding potential – stocks register. Sonnet Biotherapeutics holdings inc. (nasdaq: sonn)

Stock Profile

"Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer and is under phase 1 trial. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy and is under Phase Ib/IIa study; and SON-1210, a bispecific compound developed for solid tumor indications, including colorectal cancer. It has a license agreement with New Life Therapeutics Pte, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6. The company is headquartered in Princeton, New Jersey."

Keywords

Are looking for the most relevant information about Sonnet BioTherapeutics Holdings? Investor spend a lot of time searching for information to make investment decisions in Sonnet BioTherapeutics Holdings. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Sonnet BioTherapeutics Holdings are: Sonnet, BioTherapeutics, Holdings, Inc, SONN, Friday, Biotherapeutics, and the most common words in the summary are: therapeutic, holding, inc, pharmaceutical, biotherapeutics, stock, sonnet, . One of the sentences in the summary was: Premarket Mover: Sonnet Biotherapeutics holdings, inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #holding #inc #pharmaceutical #biotherapeutics #stock #sonnet.

Read more →

Youtube Subscribe

---